[
    {
        "source": "ABSTRACT.INTRODUCTION.\nWorking memory plays a critical role in cognitive processes which are central to our daily life. Neuroimaging studies have shown that one of the most important areas corresponding to the working memory is the dorsolateral prefrontal cortex (DLFPC). This study was aimed to assess whether bilateral modulation of the DLPFC using a noninvasive brain stimulation, namely transcranial direct current stimulation (tDCS), modifies the working memory function in healthy adults.\n\nABSTRACT.METHODS.\nIn a randomized sham-controlled cross-over study, 60 subjects (30 Males) received sham and active tDCS in two subgroups (anode left/cathode right and anode right/cathode left) of the DLPFC. Subjects were presented working memory n-back task while the reaction time and accuracy were recorded.\n\nABSTRACT.RESULTS.\nA repeated measures, mixed design ANOVA indicated a significant difference between the type of stimulation (sham vs. active) in anodal stimulation of the left DLPFC with cathodal stimulation of the right DLPFC [F(1,55)= 5.29, P=0.019], but not the inverse polarity worsened accuracy in the 2-back working memory task. There were also no statistically significant changes in speed of working memory [F(1,55)= 0.458,P=0.502] related to type or order of stimulation.\n\nABSTRACT.DISCUSSION.\nThe results would imply to a polarity dependence of bilateral tDCS of working memory. Left anodal/ right cathodal stimulation of DLPFC could impair working memory, while the reverser stimulation had no effect. Meaning that bilateral stimulation of DLFC would not be a useful procedure to improve working memory. Further studies are required to understand subtle effects of different tDCS stimulation/inhibition electrode positioning on the working memory.",
        "target": "This study examined the effects of transcranial Direct Current Stimulation (tDCS) on working memory in adults. tDCS is a type of non-invasive brain stimulation that uses low-level electrical currents to stimulate specific areas of the brain.\n\nThe study included 60 participants, 30 males, who were randomly assigned to either a sham or an active tDCS group. The tDCS was applied to the dorsolateral prefrontal cortex (DLFPC), an area of the brain associated with working memory. The participants were then asked to complete a working memory n-back task while their reaction time and accuracy were recorded.\n\nThe results showed that active tDCS of the left DLFPC with cathodal stimulation of the right DLFPC impaired working memory accuracy, while the reverse order had no effect. There were also no significant changes in speed of working memory related to the type or order of stimulation.\n\nThe results suggest that tDCS of the DLFPC may impair working memory accuracy, while the reverse order has no effect. Further studies are needed to understand the subtle effects of different tDCS stimulation/inhibition electrode positioning on working memory.&lt;/s&gt;&lt;s&gt;",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1144,
                        1239
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1240,
                        1289
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.INTRODUCTION.\nWorking memory plays a critical role in cognitive processes which are central to our daily life. Neuroimaging studies have shown that one of the most important areas corresponding to the working memory is the dorsolateral prefrontal cortex (DLFPC). This study was aimed to assess whether bilateral modulation of the DLPFC using a noninvasive brain stimulation, namely transcranial direct current stimulation (tDCS), modifies the working memory function in healthy adults.\n\nABSTRACT.METHODS.\nIn a randomized sham-controlled cross-over study, 60 subjects (30 Males) received sham and active tDCS in two subgroups (anode left/cathode right and anode right/cathode left) of the DLPFC. Subjects were presented working memory n-back task while the reaction time and accuracy were recorded.\n\nABSTRACT.RESULTS.\nA repeated measures, mixed design ANOVA indicated a significant difference between the type of stimulation (sham vs. active) in anodal stimulation of the left DLPFC with cathodal stimulation of the right DLPFC [F(1,55)= 5.29, P=0.019], but not the inverse polarity worsened accuracy in the 2-back working memory task. There were also no statistically significant changes in speed of working memory [F(1,55)= 0.458,P=0.502] related to type or order of stimulation.\n\nABSTRACT.DISCUSSION.\nThe results would imply to a polarity dependence of bilateral tDCS of working memory. Left anodal/ right cathodal stimulation of DLPFC could impair working memory, while the reverser stimulation had no effect. Meaning that bilateral stimulation of DLFC would not be a useful procedure to improve working memory. Further studies are required to understand subtle effects of different tDCS stimulation/inhibition electrode positioning on the working memory.",
        "target": "Sure, here's a simpler explanation:\n\nThe research study is about an important part of our brain that helps us remember things for a short period while we work or do tasks. This is called working memory, just like holding a thought in our mind to use in the next few seconds or minutes. Scientists wanted to understand if changing the activity in this part of the brain may improve how effectively this working memory works.\n\nTo do this, they used a safe technique to stimulate certain areas in the brain lightly. They tested this on 60 people, by giving them a task that needed using this working memory while slightly stimulating their brain. They did it in two different ways, once stimulating the left side more and another time the right side more. \n\nBy carefully studying the effects, they found that when they stimulate the left side more than the right side, these people didn't do the task as well compared to when their brain was not stimulated. Stimulating the right more than the left didn't have a big effect. \n\nThis told the scientists that trying to boost brain activity might not make working memory better and that which side is stimulated matters. They suggest more studies need to be done to understand this better.",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1144,
                        1239
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1240,
                        1289
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.INTRODUCTION.\nWorking memory plays a critical role in cognitive processes which are central to our daily life. Neuroimaging studies have shown that one of the most important areas corresponding to the working memory is the dorsolateral prefrontal cortex (DLFPC). This study was aimed to assess whether bilateral modulation of the DLPFC using a noninvasive brain stimulation, namely transcranial direct current stimulation (tDCS), modifies the working memory function in healthy adults.\n\nABSTRACT.METHODS.\nIn a randomized sham-controlled cross-over study, 60 subjects (30 Males) received sham and active tDCS in two subgroups (anode left/cathode right and anode right/cathode left) of the DLPFC. Subjects were presented working memory n-back task while the reaction time and accuracy were recorded.\n\nABSTRACT.RESULTS.\nA repeated measures, mixed design ANOVA indicated a significant difference between the type of stimulation (sham vs. active) in anodal stimulation of the left DLPFC with cathodal stimulation of the right DLPFC [F(1,55)= 5.29, P=0.019], but not the inverse polarity worsened accuracy in the 2-back working memory task. There were also no statistically significant changes in speed of working memory [F(1,55)= 0.458,P=0.502] related to type or order of stimulation.\n\nABSTRACT.DISCUSSION.\nThe results would imply to a polarity dependence of bilateral tDCS of working memory. Left anodal/ right cathodal stimulation of DLPFC could impair working memory, while the reverser stimulation had no effect. Meaning that bilateral stimulation of DLFC would not be a useful procedure to improve working memory. Further studies are required to understand subtle effects of different tDCS stimulation/inhibition electrode positioning on the working memory.",
        "target": "\nThis study looked at how a special kind of brain stimulation called transcranial direct current stimulation (tDCS) affects working memory. Working memory is like a mental notebook where we keep things we need to remember. The study found that when one area of the brain called the dorsolateral prefrontal cortex (DLFPC) was stimulated in a certain way, it actually made it harder to remember things. But, when the other area of the brain called the DLFPC was stimulated in a different way, it didn't make a difference in working memory. This means that using tDCS to stimulate both areas of the brain at the same time might not be the best way to improve working memory.\n\n\n\n",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1144,
                        1239
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1240,
                        1289
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND/AIM.\nTargeted radiotherapy of liver malignancies has found to be effective in selected patients. A key limiting factor of these therapies is the relatively low tolerance of the liver parenchyma to radiation. We sought to assess the preventive effects of a combined regimen of pentoxifylline (PTX), ursodeoxycholic acid (UDCA) and low-dose low molecular weight heparin (LMWH) on focal radiation-induced liver injury (fRILI).\n\nABSTRACT.METHODS AND MATERIALS.\nPatients with liver metastases from colorectal carcinoma who were scheduled for local ablation by radiotherapy (image-guided high-dose-rate interstitial brachytherapy) were prospectively randomized to receive PTX, UDCA and LMWH for 8 weeks (treatment) or no medication (control). Focal RILI at follow-up was assessed using functional hepatobiliary magnetic resonance imaging (MRI). A minimal threshold dose, i.e. the dose to which the outer rim of the fRILI was formerly exposed to, was quantified by merging MRI and dosimetry data.\n\nABSTRACT.RESULTS.\nResults from an intended interim-analysis made a premature termination necessary. Twenty-two patients were included in the per-protocol analysis. Minimal mean hepatic threshold dose 6 weeks after radiotherapy (primary endpoint) was significantly higher in the study treatment-group compared with the control (19.1 Gy versus 14.6 Gy, p = 0.011). Qualitative evidence of fRILI by MRI at 6 weeks was observed in 45.5% of patients in the treatment versus 90.9% of the control group. No significant differences between the groups were observed at the 12-week follow-up.\n\nABSTRACT.CONCLUSIONS.\nThe post-therapeutic application of PTX, UDCA and low-dose LMWH significantly reduced the extent and incidence fRILI at 6 weeks after radiotherapy. The development of subsequent fRILI at 12 weeks (4 weeks after cessation of PTX, UDCA and LMWH during weeks 1\u20138) in the treatment group was comparable to the control group thus supporting the observation that the agents mitigated fRILI.\n\nABSTRACT.TRIAL REGISTRATION.\nEU clinical trials register 2008-002985-70 ClinicalTrials.gov NCT01149304",
        "target": "This study investigated the effects of a combined regimen of pentoxifylline (PTX), ursodeoxycholic acid (UDCA) and low-dose low molecular weight heparin (LMWH) on focal radiation-induced liver injury (fRILI). Patients with liver metastases from colorectal carcinoma who were scheduled for local ablation by radiotherapy were prospectively randomized to receive the combined regimen or no medication. The primary endpoint was the minimal mean hepatic threshold dose 6 weeks after radiotherapy. Qualitative evidence of fRILI was observed in 45.5% of the treatment group compared to 90.9% of the control group at 6 weeks. No significant differences between the groups were observed at the 12-week follow-up. The post-therapeutic application of PTX, UDCA and LMWH significantly reduced the extent and incidence of fRILI at 6 weeks after radiotherapy. The development of subsequent fRILI at 12 weeks in the treatment group was comparable to the control group thus supporting the observation that the agents mitigated fRILI.&lt;/s&gt;&lt;s&gt;",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1175,
                        1373
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1374,
                        1593
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND/AIM.\nTargeted radiotherapy of liver malignancies has found to be effective in selected patients. A key limiting factor of these therapies is the relatively low tolerance of the liver parenchyma to radiation. We sought to assess the preventive effects of a combined regimen of pentoxifylline (PTX), ursodeoxycholic acid (UDCA) and low-dose low molecular weight heparin (LMWH) on focal radiation-induced liver injury (fRILI).\n\nABSTRACT.METHODS AND MATERIALS.\nPatients with liver metastases from colorectal carcinoma who were scheduled for local ablation by radiotherapy (image-guided high-dose-rate interstitial brachytherapy) were prospectively randomized to receive PTX, UDCA and LMWH for 8 weeks (treatment) or no medication (control). Focal RILI at follow-up was assessed using functional hepatobiliary magnetic resonance imaging (MRI). A minimal threshold dose, i.e. the dose to which the outer rim of the fRILI was formerly exposed to, was quantified by merging MRI and dosimetry data.\n\nABSTRACT.RESULTS.\nResults from an intended interim-analysis made a premature termination necessary. Twenty-two patients were included in the per-protocol analysis. Minimal mean hepatic threshold dose 6 weeks after radiotherapy (primary endpoint) was significantly higher in the study treatment-group compared with the control (19.1 Gy versus 14.6 Gy, p = 0.011). Qualitative evidence of fRILI by MRI at 6 weeks was observed in 45.5% of patients in the treatment versus 90.9% of the control group. No significant differences between the groups were observed at the 12-week follow-up.\n\nABSTRACT.CONCLUSIONS.\nThe post-therapeutic application of PTX, UDCA and low-dose LMWH significantly reduced the extent and incidence fRILI at 6 weeks after radiotherapy. The development of subsequent fRILI at 12 weeks (4 weeks after cessation of PTX, UDCA and LMWH during weeks 1\u20138) in the treatment group was comparable to the control group thus supporting the observation that the agents mitigated fRILI.\n\nABSTRACT.TRIAL REGISTRATION.\nEU clinical trials register 2008-002985-70 ClinicalTrials.gov NCT01149304",
        "target": "This passage is all about a scientific study. The researchers wanted to see if combining a few different medicines could help protect the liver during certain types of cancer treatment that are known to potentially harm it. They used two groups of people who had colorectal cancer that had spread to their livers and were going to receive this specific cancer treatment. One group received the medicine blend for two months, while the other group didn't get any extra medicine.\n\nThe researchers used special imaging to look at the livers of the patients after the cancer treatment. They found that the patients who received the extra medicines had less damage to their livers six weeks after the radiotherapy, compared to those who didn't get the extra medicines. However, by 12 weeks after the radiotherapy, the groups had similar levels of liver damage.\n\nThis basically means that while the medicine blend seemed to reduce the initial damage to the liver from the cancer treatment, it didn't necessarily prevent it completely or for a longer period of time. They suggested that these additional medicines might be useful to lessen initial liver damage in patients receiving this cancer treatment.",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1175,
                        1373
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1374,
                        1593
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND/AIM.\nTargeted radiotherapy of liver malignancies has found to be effective in selected patients. A key limiting factor of these therapies is the relatively low tolerance of the liver parenchyma to radiation. We sought to assess the preventive effects of a combined regimen of pentoxifylline (PTX), ursodeoxycholic acid (UDCA) and low-dose low molecular weight heparin (LMWH) on focal radiation-induced liver injury (fRILI).\n\nABSTRACT.METHODS AND MATERIALS.\nPatients with liver metastases from colorectal carcinoma who were scheduled for local ablation by radiotherapy (image-guided high-dose-rate interstitial brachytherapy) were prospectively randomized to receive PTX, UDCA and LMWH for 8 weeks (treatment) or no medication (control). Focal RILI at follow-up was assessed using functional hepatobiliary magnetic resonance imaging (MRI). A minimal threshold dose, i.e. the dose to which the outer rim of the fRILI was formerly exposed to, was quantified by merging MRI and dosimetry data.\n\nABSTRACT.RESULTS.\nResults from an intended interim-analysis made a premature termination necessary. Twenty-two patients were included in the per-protocol analysis. Minimal mean hepatic threshold dose 6 weeks after radiotherapy (primary endpoint) was significantly higher in the study treatment-group compared with the control (19.1 Gy versus 14.6 Gy, p = 0.011). Qualitative evidence of fRILI by MRI at 6 weeks was observed in 45.5% of patients in the treatment versus 90.9% of the control group. No significant differences between the groups were observed at the 12-week follow-up.\n\nABSTRACT.CONCLUSIONS.\nThe post-therapeutic application of PTX, UDCA and low-dose LMWH significantly reduced the extent and incidence fRILI at 6 weeks after radiotherapy. The development of subsequent fRILI at 12 weeks (4 weeks after cessation of PTX, UDCA and LMWH during weeks 1\u20138) in the treatment group was comparable to the control group thus supporting the observation that the agents mitigated fRILI.\n\nABSTRACT.TRIAL REGISTRATION.\nEU clinical trials register 2008-002985-70 ClinicalTrials.gov NCT01149304",
        "target": "\nThis is a study about medicine for people who have cancer in their liver. The medicine is called pentoxifylline, ursodeoxycholic acid, and low-dose low molecular weight heparin. The researchers wanted to see if these medicines could help prevent liver damage caused by radiation therapy. They divided the patients into two groups: one group got the medicine, and the other group did not get the medicine. They then looked at the liver damage in each group using special imaging tests. They found that the group that got the medicine had less liver damage than the group that did not get the medicine.\n\nSo, the researchers concluded that the medicine helped reduce liver damage caused by radiation therapy.",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1175,
                        1373
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1374,
                        1593
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.OBJECTIVE:\nPrimary-care (PC) settings may be an opportune place to deliver obesity interventions. Scalable interventions utilizing motivational interviewing (MI), supported by internet resources, may overcome obstacles to effective obesity treatment dissemination. This study was a randomized controlled trial (RCT) testing two web-supported interventions, motivational interviewing (MIC) and nutrition psychoeducation (NPC), an attention-control intervention, to usual care (UC).\n\nABSTRACT.DESIGN AND METHODS:\n89 overweight/obese patients, with and without binge eating disorder (BED), were randomly assigned to MIC, NPC, or UC for 3 months in PC. Patients were assessed independently at post-treatment and at 3-month follow-up\n\nABSTRACT.RESULTS:\nWeight, triglyceride levels, and depression scores decreased significantly in NPC when compared to UC but not MIC; UC and MIC did not differ significantly. Weight-loss results maintained at 3-month follow-up: approximately 25% MIC and NPC patients achieved at least 5% weight-loss which did not differ by BED status. Fidelity ratings were high and treatment adherence was associated with weight loss.\n\nABSTRACT.CONCLUSIONS:\nThis is the first RCT in PC testing MI for obesity to include an attention-control intervention (NPC). NPC, but not MI, showed a consistent pattern of superior benefits relative to UC. BED status was not associated but treatment adherence was associated with weight loss outcomes.",
        "target": "This study was a randomized controlled trial that tested two web-supported interventions, motivational interviewing (MI) and nutrition psychoeducation (NPC), against a control group of usual care (UC). The aim was to determine the effectiveness of these interventions in overweight or obese patients with or without binge eating disorder (BED).\n\nThe study included 89 participants who were randomly assigned to either MI, NPC, or UC for 3 months in primary care settings. Patients were assessed independently at post-treatment and at 3-month follow-up.\n\nThe results showed that weight, triglyceride levels, and depression scores decreased significantly in NPC when compared to UC but not MI. There were no significant differences between MI and UC. Additionally, weight-loss results maintained at 3-month follow-up: approximately 25% NPC patients achieved at least 5% weight loss, which did not differ by BED status. Fidelity ratings were high and treatment adherence was associated with weight loss.\n\nIn conclusion, this study is the first to test MI for obesity in primary care settings and the first to include an attention-control intervention (NPC). NPC, but not MI, showed a consistent pattern of superior benefits relative to UC. BED status was not associated but treatment adherence was associated with weight loss outcomes.&lt;/s&gt;&lt;s&gt;",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        757,
                        870
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.OBJECTIVE:\nPrimary-care (PC) settings may be an opportune place to deliver obesity interventions. Scalable interventions utilizing motivational interviewing (MI), supported by internet resources, may overcome obstacles to effective obesity treatment dissemination. This study was a randomized controlled trial (RCT) testing two web-supported interventions, motivational interviewing (MIC) and nutrition psychoeducation (NPC), an attention-control intervention, to usual care (UC).\n\nABSTRACT.DESIGN AND METHODS:\n89 overweight/obese patients, with and without binge eating disorder (BED), were randomly assigned to MIC, NPC, or UC for 3 months in PC. Patients were assessed independently at post-treatment and at 3-month follow-up\n\nABSTRACT.RESULTS:\nWeight, triglyceride levels, and depression scores decreased significantly in NPC when compared to UC but not MIC; UC and MIC did not differ significantly. Weight-loss results maintained at 3-month follow-up: approximately 25% MIC and NPC patients achieved at least 5% weight-loss which did not differ by BED status. Fidelity ratings were high and treatment adherence was associated with weight loss.\n\nABSTRACT.CONCLUSIONS:\nThis is the first RCT in PC testing MI for obesity to include an attention-control intervention (NPC). NPC, but not MI, showed a consistent pattern of superior benefits relative to UC. BED status was not associated but treatment adherence was associated with weight loss outcomes.",
        "target": "This study divided overweight people into three groups - some got just normal care (UC), some got to talk with a specialist about their feelings and motivation to lose weight (MIC), and some got taught about different kinds of foods and how they affect the body (NPC). They tested these three methods in a normal doctor's office. The results showed that people who learned about food (NPC) lost more weight and felt better than those who just got normal care (UC), but the ones who talked about their feelings and motivation (MIC) did not do better than normal care. The study also revealed whether you have a certain eating disorder (BED) or not did not impact the results, but if you followed the guidance as suggested, you'd lose more weight.",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        757,
                        870
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.OBJECTIVE:\nPrimary-care (PC) settings may be an opportune place to deliver obesity interventions. Scalable interventions utilizing motivational interviewing (MI), supported by internet resources, may overcome obstacles to effective obesity treatment dissemination. This study was a randomized controlled trial (RCT) testing two web-supported interventions, motivational interviewing (MIC) and nutrition psychoeducation (NPC), an attention-control intervention, to usual care (UC).\n\nABSTRACT.DESIGN AND METHODS:\n89 overweight/obese patients, with and without binge eating disorder (BED), were randomly assigned to MIC, NPC, or UC for 3 months in PC. Patients were assessed independently at post-treatment and at 3-month follow-up\n\nABSTRACT.RESULTS:\nWeight, triglyceride levels, and depression scores decreased significantly in NPC when compared to UC but not MIC; UC and MIC did not differ significantly. Weight-loss results maintained at 3-month follow-up: approximately 25% MIC and NPC patients achieved at least 5% weight-loss which did not differ by BED status. Fidelity ratings were high and treatment adherence was associated with weight loss.\n\nABSTRACT.CONCLUSIONS:\nThis is the first RCT in PC testing MI for obesity to include an attention-control intervention (NPC). NPC, but not MI, showed a consistent pattern of superior benefits relative to UC. BED status was not associated but treatment adherence was associated with weight loss outcomes.",
        "target": "\nThis study looked at how well three different ways of treating obesity worked in a doctor's office. One way, called motivational interviewing, didn't work as well as the other two ways, called nutrition psychoeducation and usual care. The nutrition psychoeducation way worked the best, and the people who got this treatment lost more weight at the 3-month follow-up. The study also found that people who were more likely to stick to the treatment plan lost more weight.\n\n",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        757,
                        870
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND.\nLow-dose haloperidol is known to be effective for the prevention of postoperative nausea and vomiting (PONV). However, precise dose-response studies have not been completed, especially in patients at high risk for PONV who require combination therapy. This study sought to identify which dose of haloperidol 1mg or 2mg could be combined with dexamethasone without adverse effects in high-risk patients undergoing gynecological laparoscopic surgery.\n\nABSTRACT.METHODS.\nFemale adults (n = 150) with three established PONV risk factors based on Apfel's score were randomized into one of three study groups. At the end of anesthesia, groups H0, H1, and H2 were given intravenous (IV) saline, haloperidol 1 mg, and haloperidol 2 mg, respectively. All patients were given dexamethasone 5 mg during the induction of anesthesia. The overall early (0\u20132 h) and late (2\u201324 h) incidences of nausea, vomiting, rescue anti-emetic administration, pain, and adverse effects (cardiac arrhythmias and extrapyramidal effects) were assessed postoperatively. The sedation score was recorded in the postanesthesia care unit (PACU).\n\nABSTRACT.RESULTS.\nThe total incidence of PONV over 24 h was significantly lower in groups H1 (29 %) and H2 (24 %) than in group H0 (54 %; P = 0.003), but there was no significant difference between groups H1 and H2. In the PACU, group H2 had a higher sedation score than groups H1 and H0 (P &lt; 0.001).\n\nABSTRACT.CONCLUSIONS.\nFor high-risk PONV patients undergoing gynecological laparoscopic surgery, when used with dexamethasone, 1-mg haloperidol was equally effective as 2 mg in terms of preventing PONV with the less sedative effect.\n\nABSTRACT.TRIAL REGISTRATION.\nClinicalTrials.gov (NCT01639599).",
        "target": "This study sought to determine the most effective and least sedative dose of haloperidol in combination with dexamethasone for preventing postoperative nausea and vomiting (PONV) in high-risk patients undergoing gynecological laparoscopic surgery. The results showed that a dose of 1 mg of haloperidol was equally effective as 2 mg in preventing PONV, but with the less sedative effect.&lt;/s&gt;&lt;s&gt;",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1348,
                        1435
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1150,
                        1347
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND.\nLow-dose haloperidol is known to be effective for the prevention of postoperative nausea and vomiting (PONV). However, precise dose-response studies have not been completed, especially in patients at high risk for PONV who require combination therapy. This study sought to identify which dose of haloperidol 1mg or 2mg could be combined with dexamethasone without adverse effects in high-risk patients undergoing gynecological laparoscopic surgery.\n\nABSTRACT.METHODS.\nFemale adults (n = 150) with three established PONV risk factors based on Apfel's score were randomized into one of three study groups. At the end of anesthesia, groups H0, H1, and H2 were given intravenous (IV) saline, haloperidol 1 mg, and haloperidol 2 mg, respectively. All patients were given dexamethasone 5 mg during the induction of anesthesia. The overall early (0\u20132 h) and late (2\u201324 h) incidences of nausea, vomiting, rescue anti-emetic administration, pain, and adverse effects (cardiac arrhythmias and extrapyramidal effects) were assessed postoperatively. The sedation score was recorded in the postanesthesia care unit (PACU).\n\nABSTRACT.RESULTS.\nThe total incidence of PONV over 24 h was significantly lower in groups H1 (29 %) and H2 (24 %) than in group H0 (54 %; P = 0.003), but there was no significant difference between groups H1 and H2. In the PACU, group H2 had a higher sedation score than groups H1 and H0 (P &lt; 0.001).\n\nABSTRACT.CONCLUSIONS.\nFor high-risk PONV patients undergoing gynecological laparoscopic surgery, when used with dexamethasone, 1-mg haloperidol was equally effective as 2 mg in terms of preventing PONV with the less sedative effect.\n\nABSTRACT.TRIAL REGISTRATION.\nClinicalTrials.gov (NCT01639599).",
        "target": "Doctors wanted to figure out the best amount of a medicine named haloperidol to give to patients undergoing a certain surgery to help prevent them from feeling sick and vomiting after their operation. They tested it on a group of women. Some got no medicine, some got 1mg of medicine, and some got 2mg. They found out that giving either 1mg or 2mg of the drug worked better than giving none at all, but there wasn't much difference between the 1mg and 2mg groups. However, the women who got 2mg felt sleepier afterwards. So, they concluded that 1mg seemed to be the best choice to prevent feeling sick without making patients too sleepy.",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1348,
                        1435
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1150,
                        1347
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND.\nLow-dose haloperidol is known to be effective for the prevention of postoperative nausea and vomiting (PONV). However, precise dose-response studies have not been completed, especially in patients at high risk for PONV who require combination therapy. This study sought to identify which dose of haloperidol 1mg or 2mg could be combined with dexamethasone without adverse effects in high-risk patients undergoing gynecological laparoscopic surgery.\n\nABSTRACT.METHODS.\nFemale adults (n = 150) with three established PONV risk factors based on Apfel's score were randomized into one of three study groups. At the end of anesthesia, groups H0, H1, and H2 were given intravenous (IV) saline, haloperidol 1 mg, and haloperidol 2 mg, respectively. All patients were given dexamethasone 5 mg during the induction of anesthesia. The overall early (0\u20132 h) and late (2\u201324 h) incidences of nausea, vomiting, rescue anti-emetic administration, pain, and adverse effects (cardiac arrhythmias and extrapyramidal effects) were assessed postoperatively. The sedation score was recorded in the postanesthesia care unit (PACU).\n\nABSTRACT.RESULTS.\nThe total incidence of PONV over 24 h was significantly lower in groups H1 (29 %) and H2 (24 %) than in group H0 (54 %; P = 0.003), but there was no significant difference between groups H1 and H2. In the PACU, group H2 had a higher sedation score than groups H1 and H0 (P &lt; 0.001).\n\nABSTRACT.CONCLUSIONS.\nFor high-risk PONV patients undergoing gynecological laparoscopic surgery, when used with dexamethasone, 1-mg haloperidol was equally effective as 2 mg in terms of preventing PONV with the less sedative effect.\n\nABSTRACT.TRIAL REGISTRATION.\nClinicalTrials.gov (NCT01639599).",
        "target": "\nThe study looked at how well a medicine called haloperidol works to prevent nausea and vomiting after surgery. The researchers wanted to know if giving haloperidol in different doses (1 mg or 2 mg) with another medicine called dexamethasone would be safe and effective for high-risk patients having laparoscopic surgery. They found that giving haloperidol in a lower dose (1 mg) worked just as well as a higher dose (2 mg) in preventing nausea and vomiting, but the lower dose caused less drowsiness in the post-anesthesia care unit (PACU).\n\nI hope this helps! Let me know if you have any other questions.",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1348,
                        1435
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1150,
                        1347
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND.\nInfants undergoing cardiac surgery are at risk of a negative protein balance, due to increased proteolysis in response to surgery and the cardiopulmonary bypass circuit, and limited intake. The aim of the study was to quantify the effect on protein kinetics of a short-term high-protein (HP) diet in infants following cardiac surgery.\n\nABSTRACT.METHODS.\nIn a prospective, double-blinded, randomized trial we compared the effects of a HP (5 g \u00b7 kg\u22121 \u00b7 d\u22121) versus normal protein (NP, 2 g \u00b7 kg\u22121 \u00b7 d\u22121) enteral diet on protein kinetics in children &lt;24 months, on day 2 following surgical repair of congenital heart disease. Valine kinetics and fractional albumin synthesis rate (FSRalb) were measured with mass spectrometry using [1-13C]valine infusion. The Mann\u2013Whitney U test was used to investigate differences between group medians. Additionally, the Hodges-Lehmann procedure was used to create a confidence interval with a point estimate of median differences between groups.\n\nABSTRACT.RESULTS.\nTwenty-eight children (median age 9 months, median weight 7 kg) participated in the study, of whom in only 20 subjects isotopic data could be used for final calculations. Due to underpowering of our study, we could not draw conclusions on the primary outcome parameters. We observed valine synthesis rate of 2.73 (range: 0.94 to 3.36) and 2.26 (1.85 to 2.73) \u03bcmol \u00b7 kg\u22121 \u00b7 min\u22121 in the HP and NP diet, respectively. The net valine balance was 0.54 (\u22120.73 to 1.75) and 0.24 (\u22120.20 to 0.63) \u03bcmol \u00b7 kg\u22121 \u00b7 min\u22121 in the HP and NP group. Between groups, there was no difference in FSRalb. We observed increased oxidation and BUN in the HP diet, compared to the NP diet, as a plausible explanation of the metabolic fate of surplus protein.\n\nABSTRACT.CONCLUSIONS.\nIt is plausible that the surplus protein in the HP group has caused the increase of valine oxidation and ureagenesis, compared to the NP group. Because too few patients had completed the study, we were unable to draw conclusions on the effect of a HP diet on protein synthesis and balance. We present our results as new hypothesis generating data.\n\nABSTRACT.TRIAL REGISTRATION.\nDutch Trial Register NTR2334.",
        "target": "This study investigated the effect of a high-protein diet on protein kinetics in infants following cardiac surgery. Twenty-eight children, aged 9 months and weighing 7 kg on average, participated in the study. The results showed that the net valine balance was 0.54 (\u22120.73 to 1.75) and 0.24 (\u22120.20 to 0.63) \u03bcmol\u00b7kg\u00b7min\u22121 in the high-protein and normal-protein diet groups, respectively. Additionally, the high-protein diet increased valine oxidation and ureagenesis, compared to the normal-protein diet. These results suggest that a high-protein diet may have a positive effect on protein kinetics in infants following cardiac surgery.&lt;/s&gt;&lt;s&gt;",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1555,
                        1605
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1193,
                        1291
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND.\nInfants undergoing cardiac surgery are at risk of a negative protein balance, due to increased proteolysis in response to surgery and the cardiopulmonary bypass circuit, and limited intake. The aim of the study was to quantify the effect on protein kinetics of a short-term high-protein (HP) diet in infants following cardiac surgery.\n\nABSTRACT.METHODS.\nIn a prospective, double-blinded, randomized trial we compared the effects of a HP (5 g \u00b7 kg\u22121 \u00b7 d\u22121) versus normal protein (NP, 2 g \u00b7 kg\u22121 \u00b7 d\u22121) enteral diet on protein kinetics in children &lt;24 months, on day 2 following surgical repair of congenital heart disease. Valine kinetics and fractional albumin synthesis rate (FSRalb) were measured with mass spectrometry using [1-13C]valine infusion. The Mann\u2013Whitney U test was used to investigate differences between group medians. Additionally, the Hodges-Lehmann procedure was used to create a confidence interval with a point estimate of median differences between groups.\n\nABSTRACT.RESULTS.\nTwenty-eight children (median age 9 months, median weight 7 kg) participated in the study, of whom in only 20 subjects isotopic data could be used for final calculations. Due to underpowering of our study, we could not draw conclusions on the primary outcome parameters. We observed valine synthesis rate of 2.73 (range: 0.94 to 3.36) and 2.26 (1.85 to 2.73) \u03bcmol \u00b7 kg\u22121 \u00b7 min\u22121 in the HP and NP diet, respectively. The net valine balance was 0.54 (\u22120.73 to 1.75) and 0.24 (\u22120.20 to 0.63) \u03bcmol \u00b7 kg\u22121 \u00b7 min\u22121 in the HP and NP group. Between groups, there was no difference in FSRalb. We observed increased oxidation and BUN in the HP diet, compared to the NP diet, as a plausible explanation of the metabolic fate of surplus protein.\n\nABSTRACT.CONCLUSIONS.\nIt is plausible that the surplus protein in the HP group has caused the increase of valine oxidation and ureagenesis, compared to the NP group. Because too few patients had completed the study, we were unable to draw conclusions on the effect of a HP diet on protein synthesis and balance. We present our results as new hypothesis generating data.\n\nABSTRACT.TRIAL REGISTRATION.\nDutch Trial Register NTR2334.",
        "target": "This study is about babies who have heart surgery. After surgery, they might not get enough protein, which is important for their strength and recovery. The study wanted to see the effects of giving these babies a special high-protein diet. \n\nThey did this experiment with 28 little kids who had heart surgery. They gave some of them regular food and some others food with extra protein. Then, they measured the levels of a protein called valine and something else called albumin in their bodies. \n\nBut they had some problems with their experiment. Firstly, they didn't have enough babies to make clear conclusions. And secondly, some of the data from the tests they did couldn't be used in the end. \n\nWhat they did find was that the babies who were given the extra protein had a little more valine in their bodies. But that didn't make a difference in how much albumin they had. Also, the babies on the high protein diet had higher levels of something called oxidation and BUN. This could mean that the extra protein was being turned into energy instead of being used to make more protein.\n\nIn the end, they couldn't say for sure whether the high-protein diet helped the babies build more protein after their surgery. But they think they may be on to something and want to do more studies to figure it out.",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1555,
                        1605
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1193,
                        1291
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND.\nInfants undergoing cardiac surgery are at risk of a negative protein balance, due to increased proteolysis in response to surgery and the cardiopulmonary bypass circuit, and limited intake. The aim of the study was to quantify the effect on protein kinetics of a short-term high-protein (HP) diet in infants following cardiac surgery.\n\nABSTRACT.METHODS.\nIn a prospective, double-blinded, randomized trial we compared the effects of a HP (5 g \u00b7 kg\u22121 \u00b7 d\u22121) versus normal protein (NP, 2 g \u00b7 kg\u22121 \u00b7 d\u22121) enteral diet on protein kinetics in children &lt;24 months, on day 2 following surgical repair of congenital heart disease. Valine kinetics and fractional albumin synthesis rate (FSRalb) were measured with mass spectrometry using [1-13C]valine infusion. The Mann\u2013Whitney U test was used to investigate differences between group medians. Additionally, the Hodges-Lehmann procedure was used to create a confidence interval with a point estimate of median differences between groups.\n\nABSTRACT.RESULTS.\nTwenty-eight children (median age 9 months, median weight 7 kg) participated in the study, of whom in only 20 subjects isotopic data could be used for final calculations. Due to underpowering of our study, we could not draw conclusions on the primary outcome parameters. We observed valine synthesis rate of 2.73 (range: 0.94 to 3.36) and 2.26 (1.85 to 2.73) \u03bcmol \u00b7 kg\u22121 \u00b7 min\u22121 in the HP and NP diet, respectively. The net valine balance was 0.54 (\u22120.73 to 1.75) and 0.24 (\u22120.20 to 0.63) \u03bcmol \u00b7 kg\u22121 \u00b7 min\u22121 in the HP and NP group. Between groups, there was no difference in FSRalb. We observed increased oxidation and BUN in the HP diet, compared to the NP diet, as a plausible explanation of the metabolic fate of surplus protein.\n\nABSTRACT.CONCLUSIONS.\nIt is plausible that the surplus protein in the HP group has caused the increase of valine oxidation and ureagenesis, compared to the NP group. Because too few patients had completed the study, we were unable to draw conclusions on the effect of a HP diet on protein synthesis and balance. We present our results as new hypothesis generating data.\n\nABSTRACT.TRIAL REGISTRATION.\nDutch Trial Register NTR2334.",
        "target": "\nThe researchers wanted to know if giving infants a high-protein diet after heart surgery would help them build more muscle. They gave some infants a special diet with extra protein and others a normal diet with less protein. They measured how much protein the infants were using and how much they were making. They found that the infants who got the extra protein had more oxidation and ureagenesis (a process that uses protein to make other things in the body). They couldn't tell if the high-protein diet helped the infants build more muscle because too few infants finished the study. They think it might be because the extra protein made the infants use up more protein in other ways.",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1555,
                        1605
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1193,
                        1291
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND:.\nIn the United Kingdom, totally implantable venous access systems (TIVAS) are not routinely used. Compared with Hickman catheters, these devices are more expensive and complex to insert. However, it is unclear whether the higher costs may be offset by perceived greater health benefits. This pilot trial aimed to generate relevant data to inform the design of a larger definitive randomised controlled trial.\n\nABSTRACT.METHODS:.\nThis was a phase II prospective, randomised, open trial from two UK oncology centres. The primary end point was overall complication rate. Secondary end points included individual complication rates, time to first complication and quality of life. Analysis was by intention to treat. An economic evaluation was also carried out.\n\nABSTRACT.RESULTS:.\nA total of 100 patients were randomised in a 3 : 1 ratio to receive a Hickman or a TIVAS. Overall, 54% of patients in the Hickman arm suffered one or more complications compared with 38% in the TIVAS arm (one-sided P=0.068). In the Hickman arm, 28% of the devices were removed prematurely due to a complication compared with 4% in the TIVAS arm. Quality of life based on the device-specific questionnaire was greater in the TIVAS arm for 13 of the 16 questions. The economic evaluation showed that Hickman arm was associated with greater mean cost per patient \u00a31803 (95% CI 462, 3215), but similar quality-adjusted life years \u22120.01 (95% CI \u22120.15, 0.15) than the TIVAS arm. However, there is much uncertainty associated with the results.\n\nABSTRACT.CONCLUSIONS:.\nCompared with Hickman catheters, TIVAS may be the cost-effective option. A larger multicentre trial is needed to confirm these preliminary findings.",
        "target": "This study compared the costs and benefits of two types of venous access systems for people with cancer in the United Kingdom. The results showed that the TIVAS had a lower overall complication rate than Hickman catheters, but were more expensive and required more complex insertion. Quality of life was better for the TIVAS patients, but there was much uncertainty around the results. Therefore, it is not yet clear whether the higher costs of the TIVAS may be offset by the perceived greater health benefits. A larger multicentre trial is needed to confirm these preliminary findings.&lt;/s&gt;&lt;s&gt;",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        889,
                        1022
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND:.\nIn the United Kingdom, totally implantable venous access systems (TIVAS) are not routinely used. Compared with Hickman catheters, these devices are more expensive and complex to insert. However, it is unclear whether the higher costs may be offset by perceived greater health benefits. This pilot trial aimed to generate relevant data to inform the design of a larger definitive randomised controlled trial.\n\nABSTRACT.METHODS:.\nThis was a phase II prospective, randomised, open trial from two UK oncology centres. The primary end point was overall complication rate. Secondary end points included individual complication rates, time to first complication and quality of life. Analysis was by intention to treat. An economic evaluation was also carried out.\n\nABSTRACT.RESULTS:.\nA total of 100 patients were randomised in a 3 : 1 ratio to receive a Hickman or a TIVAS. Overall, 54% of patients in the Hickman arm suffered one or more complications compared with 38% in the TIVAS arm (one-sided P=0.068). In the Hickman arm, 28% of the devices were removed prematurely due to a complication compared with 4% in the TIVAS arm. Quality of life based on the device-specific questionnaire was greater in the TIVAS arm for 13 of the 16 questions. The economic evaluation showed that Hickman arm was associated with greater mean cost per patient \u00a31803 (95% CI 462, 3215), but similar quality-adjusted life years \u22120.01 (95% CI \u22120.15, 0.15) than the TIVAS arm. However, there is much uncertainty associated with the results.\n\nABSTRACT.CONCLUSIONS:.\nCompared with Hickman catheters, TIVAS may be the cost-effective option. A larger multicentre trial is needed to confirm these preliminary findings.",
        "target": "This passage is about an experiment that was done to see if a type of equipment used for getting medicine into the bloodstream, called TIVAS, was better to use in the UK. Right now, another tool called a Hickman catheter is used more often, but the researchers wanted to see if TIVAS, even though they are more expensive and harder to put in, could be better in the long run.\n\nThe researchers got 100 patients together and randomly chose some to use the Hickman catheter and some to use the TIVAS. They then kept track of any troubles that came up and how the patients felt while using the devices.\n\nThey found that more patients using the Hickman catheter had problems and had to have their devices taken out early. When they asked the patients how they felt about their equipment, patients with TIVAS scored higher on most questions. \n\nEven though it cost a bit more to use TIVAS, because they caused fewer problems and patients liked them more, the researchers think it could be a better choice. But they need to do more research with more patients to be sure.",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        889,
                        1022
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND:.\nIn the United Kingdom, totally implantable venous access systems (TIVAS) are not routinely used. Compared with Hickman catheters, these devices are more expensive and complex to insert. However, it is unclear whether the higher costs may be offset by perceived greater health benefits. This pilot trial aimed to generate relevant data to inform the design of a larger definitive randomised controlled trial.\n\nABSTRACT.METHODS:.\nThis was a phase II prospective, randomised, open trial from two UK oncology centres. The primary end point was overall complication rate. Secondary end points included individual complication rates, time to first complication and quality of life. Analysis was by intention to treat. An economic evaluation was also carried out.\n\nABSTRACT.RESULTS:.\nA total of 100 patients were randomised in a 3 : 1 ratio to receive a Hickman or a TIVAS. Overall, 54% of patients in the Hickman arm suffered one or more complications compared with 38% in the TIVAS arm (one-sided P=0.068). In the Hickman arm, 28% of the devices were removed prematurely due to a complication compared with 4% in the TIVAS arm. Quality of life based on the device-specific questionnaire was greater in the TIVAS arm for 13 of the 16 questions. The economic evaluation showed that Hickman arm was associated with greater mean cost per patient \u00a31803 (95% CI 462, 3215), but similar quality-adjusted life years \u22120.01 (95% CI \u22120.15, 0.15) than the TIVAS arm. However, there is much uncertainty associated with the results.\n\nABSTRACT.CONCLUSIONS:.\nCompared with Hickman catheters, TIVAS may be the cost-effective option. A larger multicentre trial is needed to confirm these preliminary findings.",
        "target": "\nThe researchers looked at two different ways to get chemotherapy into a person's body. One way is called a Hickman catheter, and the other is called a totally implantable venous access system (TIVAS). They found that the TIVAS might be better because it was less likely to cause problems or have to be removed early. But they also found that the TIVAS was more expensive. They need to do more research to confirm their findings.\n\nDoes that make sense?",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        889,
                        1022
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND.\nThe present study examined the effects of a balance-based exergaming intervention using the Kinect sensor on postural stability and balance in people with Parkinson's disease (PD).\n\nABSTRACT.METHODS.\nWe conducted a subject-blinded, randomized controlled study. Twenty people with PD (Hoehn and Yahr stages I through III) were recruited and randomly assigned to either a balance-based exergaming group (N = 10) or a balance training group (N = 10) for an 8-week balance training period. Postural stability was assessed using the limits of stability (LOS) and one-leg stance (OLS) tests. Balance was assessed using the Berg Balance Scale (BBS) and the timed up and go (TUG) test. Participants were assessed pre- and post-training.\n\nABSTRACT.RESULTS.\nAfter training, participants in the balance-based exergaming group showed significant improvements in LOS performance, and in the eyes-closed condition of the OLS test. Both training programs led to improvements in BBS and TUG performance. Furthermore, balance-based exergaming training resulted in significantly better performance in directional control in the LOS test (78.9 \u00b1 7.65 %) compared with conventional balance training (70.6 \u00b1 9.37 %).\n\nABSTRACT.CONCLUSIONS.\nBalance-based exergaming training resulted in a greater improvement in postural stability compared with conventional balance training. Our results support the therapeutic use of exergaming aided by the Kinect sensor in people with PD.\n\nABSTRACT.TRIAL REGISTRATION.\nClinicalTrials.gov.NCT02671396\n\nABSTRACT.ELECTRONIC SUPPLEMENTARY MATERIAL.\nThe online version of this article (doi:10.1186/s12984-016-0185-y) contains supplementary material, which is available to authorized users.",
        "target": "This study examined the effects of a balance-based exergaming intervention using the Kinect sensor on postural stability and balance in people with Parkinson's disease (PD).\n\nThe study had a subject-blinded, randomized controlled design. Twenty people with PD (Hoehn and Yahr stages I through III) were recruited and randomly assigned to either a balance-based exergaming group (N = 10) or a balance training group (N = 10) for an 8-week balance training period. Postural stability was assessed using the limits of stability (LOS) and one-leg stance (OLS) tests. Balance was assessed using the Berg Balance Scale (BBS) and the timed up and go (TUG) test. Participants were assessed pre- and post-training.\n\nAfter training, participants in the balance-based exergaming group showed significant improvements in LOS performance, and in the eyes-closed condition of the OLS test. Both training programs led to improvements in BBS and TUG performance. Furthermore, balance-based exergaming training resulted in significantly better performance in the directional control in the LOS test (78.9 \u00b1 7.65 %) compared with conventional balance training (70.6 \u00b1 9.37 %).\n\nThe results of this study suggest that balance-based exergaming training is more effective than conventional balance training for improving postural stability in people with PD. The use of the Kinect sensor may be beneficial for improving balance and postural stability in people with PD.&lt;/s&gt;&lt;s&gt;",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        769,
                        937
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1009,
                        1216
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND.\nThe present study examined the effects of a balance-based exergaming intervention using the Kinect sensor on postural stability and balance in people with Parkinson's disease (PD).\n\nABSTRACT.METHODS.\nWe conducted a subject-blinded, randomized controlled study. Twenty people with PD (Hoehn and Yahr stages I through III) were recruited and randomly assigned to either a balance-based exergaming group (N = 10) or a balance training group (N = 10) for an 8-week balance training period. Postural stability was assessed using the limits of stability (LOS) and one-leg stance (OLS) tests. Balance was assessed using the Berg Balance Scale (BBS) and the timed up and go (TUG) test. Participants were assessed pre- and post-training.\n\nABSTRACT.RESULTS.\nAfter training, participants in the balance-based exergaming group showed significant improvements in LOS performance, and in the eyes-closed condition of the OLS test. Both training programs led to improvements in BBS and TUG performance. Furthermore, balance-based exergaming training resulted in significantly better performance in directional control in the LOS test (78.9 \u00b1 7.65 %) compared with conventional balance training (70.6 \u00b1 9.37 %).\n\nABSTRACT.CONCLUSIONS.\nBalance-based exergaming training resulted in a greater improvement in postural stability compared with conventional balance training. Our results support the therapeutic use of exergaming aided by the Kinect sensor in people with PD.\n\nABSTRACT.TRIAL REGISTRATION.\nClinicalTrials.gov.NCT02671396\n\nABSTRACT.ELECTRONIC SUPPLEMENTARY MATERIAL.\nThe online version of this article (doi:10.1186/s12984-016-0185-y) contains supplementary material, which is available to authorized users.",
        "target": "Researchers wanted to see if using a special video game (based on balance and using the Kinect sensor) could help people with Parkinson's disease to improve their balance and make their body posture more stable. They ran an experiment with 20 people suffering from Parkinson's disease. Half of these people used the video game for trianing and the other half did regular balance training for 8 weeks. They tested everyone's balance and posture before and after the training. \n\nThe results showed that those who played the video game had better improvement in their balance and body posture than the ones who did regular balance training. Even when they closed their eyes, they were still more stable than before. Thus, the study helps to show that using such video games could be beneficial for people with Parkinson's disease to improve their balance and posture.",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        769,
                        937
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1009,
                        1216
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND.\nThe present study examined the effects of a balance-based exergaming intervention using the Kinect sensor on postural stability and balance in people with Parkinson's disease (PD).\n\nABSTRACT.METHODS.\nWe conducted a subject-blinded, randomized controlled study. Twenty people with PD (Hoehn and Yahr stages I through III) were recruited and randomly assigned to either a balance-based exergaming group (N = 10) or a balance training group (N = 10) for an 8-week balance training period. Postural stability was assessed using the limits of stability (LOS) and one-leg stance (OLS) tests. Balance was assessed using the Berg Balance Scale (BBS) and the timed up and go (TUG) test. Participants were assessed pre- and post-training.\n\nABSTRACT.RESULTS.\nAfter training, participants in the balance-based exergaming group showed significant improvements in LOS performance, and in the eyes-closed condition of the OLS test. Both training programs led to improvements in BBS and TUG performance. Furthermore, balance-based exergaming training resulted in significantly better performance in directional control in the LOS test (78.9 \u00b1 7.65 %) compared with conventional balance training (70.6 \u00b1 9.37 %).\n\nABSTRACT.CONCLUSIONS.\nBalance-based exergaming training resulted in a greater improvement in postural stability compared with conventional balance training. Our results support the therapeutic use of exergaming aided by the Kinect sensor in people with PD.\n\nABSTRACT.TRIAL REGISTRATION.\nClinicalTrials.gov.NCT02671396\n\nABSTRACT.ELECTRONIC SUPPLEMENTARY MATERIAL.\nThe online version of this article (doi:10.1186/s12984-016-0185-y) contains supplementary material, which is available to authorized users.",
        "target": "\nThe researchers studied how well people with Parkinson's disease (PD) can balance themselves. They wanted to know if playing a video game that requires balance and movement would help improve their balance. They divided the participants into two groups: one that played a balance-based video game and one that did regular balance training. They tested the participants' balance before and after the training and found that the group that played the video game improved more than the other group. They think that playing the video game can help people with PD improve their balance more than regular balance training.\n\nSo, in simpler terms, the researchers looked at how well people with Parkinson's disease can balance themselves. They created two groups: one that played a video game that required balance and movement, and one that did regular balance training. After testing the participants' balance before and after the training, they found that the group that played the video game improved more than the other group. This suggests that playing video games can help people with Parkinson's disease improve their balance more than regular balance training.",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        769,
                        937
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1009,
                        1216
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND:.\nRecently, the use of ketamine as a systemic and local analgesic drug in reducing post-operative pain is studied more frequently.\n\nABSTRACT.OBJECTIVES:.\nThe aim of the present study was to assess the analgesic efficacy of IV ketamine injection inaddition to nephrostomy tract infiltration of ketamine-bupivacaine on postoperative pain relief after tubeless percutaneous nephrolithotomy (PCNL).\n\nABSTRACT.PATIENTS AND METHODS:.\nPatients (n = 100), with renal stone who were candidates for PCNL were randomized to five groups with 20 cases in each: Group C, 10 mL of saline solution was infiltrated into the nephrostomy tract; Group B, 10 mL of 0.25% bupivacaine was infiltrated into the nephrostomy tract; Group BK1, 10 mL of 0.25% bupivacaine plus 0.5 mg/kg ketamine was infiltrated into the nephrostomy tract; Group BK2, 10 mL of 0.25% bupivacaine plus 1.5 mg/kg ketamine was infiltrated into the nephrostomy tract; Group K, 10 mL of saline solution containing 0.5 mg/kg ketamine was intravenously administered. Post-operative pain scores were compared between groups as the primary objective. Comparison of Sedation Scores, rescue analgesic consumption, time to the first rescue analgesics administration, hemodynamic and SpO2 values were regarded as the secondary objective. \n\nABSTRACT.RESULTS:.\nMean VAS scores in the first 30 min and total analgesic consumption in the first 24 h of post-operative period were significantly lower in groups BK1 and BK2 in comparison with the other groups (P &lt; 0.05). Also, time to first rescue analgesics administration was longer in the same groups (P &lt; 0.05). \n\nABSTRACT.CONCLUSIONS:.\nInfiltration of ketamine plus bupivacaine provides superior analgesic effects in PCNL surgery compared with other methods. ",
        "target": "Recently, the use of ketamine as a systemic and local analgesic drug in reducing post-operative pain is studied more frequently. The aim of the present study was to assess the analgesic efficacy of IV ketamine injection in addition to nephrostomy tract infiltration of ketamine-bupivacaine on postoperative pain relief after tubeless percutaneous nephrolithotomy (PCNL).\n\nPatients (n = 100), with renal stone who were candidates for PCNL were randomized to five groups with 20 cases in each: Group C, 10 mL of saline solution was infiltrated into the nephrostomy tract; Group B, 10 mL of 0.25% bupivacaine was infiltrated into the nephrostomy tract; Group BK1, 10 mL of 0.25% bupivacaine plus 0.5 mg/kg ketamine was infiltrated into the nephrostomy tract; Group BK2, 10 mL of 0.25% bupivacaine plus 1.5 mg/kg ketamine was infiltrated into the nephrostomy tract; Group K, 10 mL of saline solution containing 0.5 mg/kg ketamine was intravenously administered. Post-operative pain scores were compared between groups as the primary objective. Comparison of Sedation Scores, rescue analgesic consumption, time to the first rescue analgesics administration, hemodynamic and SpO2 values were regarded as the secondary objective.\n\nMean VAS scores in the first 30 min and total analgesic consumption in the first 24 h of post-operative period were significantly lower in groups BK1 and BK2 in comparison with the other groups (P &lt; 0.05). Also, time to first rescue analgesics administration was longer in the same groups (P &lt; 0.05).\n\nInfiltration of ketamine plus bupivacaine provides superior analgesic effects in PCNL surgery compared with other methods.&lt;/s&gt;&lt;s&gt;",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1320,
                        1626
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND:.\nRecently, the use of ketamine as a systemic and local analgesic drug in reducing post-operative pain is studied more frequently.\n\nABSTRACT.OBJECTIVES:.\nThe aim of the present study was to assess the analgesic efficacy of IV ketamine injection inaddition to nephrostomy tract infiltration of ketamine-bupivacaine on postoperative pain relief after tubeless percutaneous nephrolithotomy (PCNL).\n\nABSTRACT.PATIENTS AND METHODS:.\nPatients (n = 100), with renal stone who were candidates for PCNL were randomized to five groups with 20 cases in each: Group C, 10 mL of saline solution was infiltrated into the nephrostomy tract; Group B, 10 mL of 0.25% bupivacaine was infiltrated into the nephrostomy tract; Group BK1, 10 mL of 0.25% bupivacaine plus 0.5 mg/kg ketamine was infiltrated into the nephrostomy tract; Group BK2, 10 mL of 0.25% bupivacaine plus 1.5 mg/kg ketamine was infiltrated into the nephrostomy tract; Group K, 10 mL of saline solution containing 0.5 mg/kg ketamine was intravenously administered. Post-operative pain scores were compared between groups as the primary objective. Comparison of Sedation Scores, rescue analgesic consumption, time to the first rescue analgesics administration, hemodynamic and SpO2 values were regarded as the secondary objective. \n\nABSTRACT.RESULTS:.\nMean VAS scores in the first 30 min and total analgesic consumption in the first 24 h of post-operative period were significantly lower in groups BK1 and BK2 in comparison with the other groups (P &lt; 0.05). Also, time to first rescue analgesics administration was longer in the same groups (P &lt; 0.05). \n\nABSTRACT.CONCLUSIONS:.\nInfiltration of ketamine plus bupivacaine provides superior analgesic effects in PCNL surgery compared with other methods. ",
        "target": "This is a science experiment about making people feel less pain after kidney surgery. They tested 100 patients and split them into five groups, trying different pain medications with each group. Turns out, the groups given a mix of two specific medications, ketamine and bupivacaine, felt less pain and needed fewer extra pain medicines than the other groups. So, combining these two drugs works better for minimizing surgical pain.",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1320,
                        1626
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.BACKGROUND:.\nRecently, the use of ketamine as a systemic and local analgesic drug in reducing post-operative pain is studied more frequently.\n\nABSTRACT.OBJECTIVES:.\nThe aim of the present study was to assess the analgesic efficacy of IV ketamine injection inaddition to nephrostomy tract infiltration of ketamine-bupivacaine on postoperative pain relief after tubeless percutaneous nephrolithotomy (PCNL).\n\nABSTRACT.PATIENTS AND METHODS:.\nPatients (n = 100), with renal stone who were candidates for PCNL were randomized to five groups with 20 cases in each: Group C, 10 mL of saline solution was infiltrated into the nephrostomy tract; Group B, 10 mL of 0.25% bupivacaine was infiltrated into the nephrostomy tract; Group BK1, 10 mL of 0.25% bupivacaine plus 0.5 mg/kg ketamine was infiltrated into the nephrostomy tract; Group BK2, 10 mL of 0.25% bupivacaine plus 1.5 mg/kg ketamine was infiltrated into the nephrostomy tract; Group K, 10 mL of saline solution containing 0.5 mg/kg ketamine was intravenously administered. Post-operative pain scores were compared between groups as the primary objective. Comparison of Sedation Scores, rescue analgesic consumption, time to the first rescue analgesics administration, hemodynamic and SpO2 values were regarded as the secondary objective. \n\nABSTRACT.RESULTS:.\nMean VAS scores in the first 30 min and total analgesic consumption in the first 24 h of post-operative period were significantly lower in groups BK1 and BK2 in comparison with the other groups (P &lt; 0.05). Also, time to first rescue analgesics administration was longer in the same groups (P &lt; 0.05). \n\nABSTRACT.CONCLUSIONS:.\nInfiltration of ketamine plus bupivacaine provides superior analgesic effects in PCNL surgery compared with other methods. ",
        "target": "\nThe study looked at how well different ways of giving ketamine and bupivacaine (a pain medicine) worked to reduce pain after a surgery called tubeless percutaneous nephrolithotomy (PCNL). The researchers found that giving ketamine and bupivacaine together through a tube in the kidney area was the most effective way to reduce pain after the surgery. They also found that it took longer for people to need more pain medicine after this treatment.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Debug.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\u754c.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nVS.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS\n\nMS Windows MS SQL SQL Windows 20.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows Windows MS SQL Windows 0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS Windows 0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS Windows 0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS 0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS \n\n\n\n\nMS \n\n\n\nMS \n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\nMS \nMS \n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\nMS \n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\nMS \n\nMS 0\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS \n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\nMS Windows MS 0\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n MS Windows MS 0\n\n\n\n\n\n\n\n\n\n\n\n MS Windows MS ",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1320,
                        1626
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.OBJECTIVE.\nThe purpose of this study was to determine the effects of carbonated water on etched or sealed enamel according to the carbonation level and the presence of calcium ions.\n\nABSTRACT.METHODS.\nCarbonated water with different carbonation levels was manufactured by a soda carbonator. Seventy-five premolar teeth were randomly divided into a control group and 4 experimental groups in accordance with the carbonation level and the presence of calcium ions in the test solutions. After specimen preparation of the Unexposed, Etched, and Sealed enamel subgroups, all the specimens were submerged in each test solution for 15 minutes three times a day during 7 days. Microhardness tests on the Unexposed and Etched enamel subgroups were performed with 10 specimens from each group. Scanning electron microscopy (SEM) tests on the Unexposed, Etched, and Sealed enamel subgroups were performed with 5 specimens from each group. Microhardness changes in different groups were statistically compared using paired t-tests, the Wilcoxon signed rank test, and the Kruskal-Wallis test.\n\nABSTRACT.RESULTS.\nThe microhardness changes were significantly different between the groups (p = 0.000). The microhardness changes in all experimental groups except Group 3 (low-level carbonated water with calcium ions) were significantly greater than those in the Control group. SEM showed that etched areas of the specimen were affected by carbonated water and the magnitude of destruction varied between groups. Adhesive material was partially removed in groups exposed to carbonated water.\n\nABSTRACT.CONCLUSIONS.\nCarbonated water has negative effects on etched or sealed enamel, resulting in decreased microhardness and removal of the adhesive material.",
        "target": "This study examined the effects of carbonated water on etched or sealed enamel. Carbonated water was created with a soda carbonator and its effects were compared to a control group. Seventy-five premolar teeth were randomly divided into four experimental groups, depending on the carbonation level and the presence of calcium ions in the test solutions. After preparation of the Unexposed, Etched, and Sealed enamel subgroups, the specimens were submerged in each test solution for 15 minutes three times a day for 7 days. Microhardness tests were performed on the Unexposed and Etched enamel subgroups, and scanning electron microscopy (SEM) tests on the Unexposed, Etched, and Sealed enamel subgroups. The results showed that carbonated water had a negative effect on etched or sealed enamel, resulting in decreased microhardness and removal of the adhesive material.&lt;/s&gt;&lt;s&gt;",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1196,
                        1370
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.OBJECTIVE.\nThe purpose of this study was to determine the effects of carbonated water on etched or sealed enamel according to the carbonation level and the presence of calcium ions.\n\nABSTRACT.METHODS.\nCarbonated water with different carbonation levels was manufactured by a soda carbonator. Seventy-five premolar teeth were randomly divided into a control group and 4 experimental groups in accordance with the carbonation level and the presence of calcium ions in the test solutions. After specimen preparation of the Unexposed, Etched, and Sealed enamel subgroups, all the specimens were submerged in each test solution for 15 minutes three times a day during 7 days. Microhardness tests on the Unexposed and Etched enamel subgroups were performed with 10 specimens from each group. Scanning electron microscopy (SEM) tests on the Unexposed, Etched, and Sealed enamel subgroups were performed with 5 specimens from each group. Microhardness changes in different groups were statistically compared using paired t-tests, the Wilcoxon signed rank test, and the Kruskal-Wallis test.\n\nABSTRACT.RESULTS.\nThe microhardness changes were significantly different between the groups (p = 0.000). The microhardness changes in all experimental groups except Group 3 (low-level carbonated water with calcium ions) were significantly greater than those in the Control group. SEM showed that etched areas of the specimen were affected by carbonated water and the magnitude of destruction varied between groups. Adhesive material was partially removed in groups exposed to carbonated water.\n\nABSTRACT.CONCLUSIONS.\nCarbonated water has negative effects on etched or sealed enamel, resulting in decreased microhardness and removal of the adhesive material.",
        "target": "Scientists wanted to find out what happens to tooth enamel (the hard, outer layer of your tooth) when it's exposed to fizzy water that has different levels of fizz and calcium (a mineral that helps keep your teeth and bones strong). \n\nTo do this, they used a machine to make fizzy water with different amounts of bubbles. They then got 75 different teeth and split them into different groups, each group having different conditions for testing. Some teeth were left as they were, some were made softer using a special solution, and some were coated with a protective seal.\n\nThey then dipped these teeth into the different fizzy waters for 15 minutes, three times a day for seven days. After that, they measured how hard or soft the teeth had become and looked closely at them with a super powerful microscope.\n\nThey found that the teeth that were dipped in the fizzy water were softer and had a rougher surface compared to the teeth that were not. Interestingly, the teeth that were exposed to low-level fizzy water with calcium didn't change as much.\n\nThis means that fizzy water can potentially damage your teeth by making them softer and could even remove materials used by dentists to protect or fix teeth. This is why it's important to not drink too much fizzy water and to also make sure your diet has enough calcium.",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1196,
                        1370
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.OBJECTIVE.\nThe purpose of this study was to determine the effects of carbonated water on etched or sealed enamel according to the carbonation level and the presence of calcium ions.\n\nABSTRACT.METHODS.\nCarbonated water with different carbonation levels was manufactured by a soda carbonator. Seventy-five premolar teeth were randomly divided into a control group and 4 experimental groups in accordance with the carbonation level and the presence of calcium ions in the test solutions. After specimen preparation of the Unexposed, Etched, and Sealed enamel subgroups, all the specimens were submerged in each test solution for 15 minutes three times a day during 7 days. Microhardness tests on the Unexposed and Etched enamel subgroups were performed with 10 specimens from each group. Scanning electron microscopy (SEM) tests on the Unexposed, Etched, and Sealed enamel subgroups were performed with 5 specimens from each group. Microhardness changes in different groups were statistically compared using paired t-tests, the Wilcoxon signed rank test, and the Kruskal-Wallis test.\n\nABSTRACT.RESULTS.\nThe microhardness changes were significantly different between the groups (p = 0.000). The microhardness changes in all experimental groups except Group 3 (low-level carbonated water with calcium ions) were significantly greater than those in the Control group. SEM showed that etched areas of the specimen were affected by carbonated water and the magnitude of destruction varied between groups. Adhesive material was partially removed in groups exposed to carbonated water.\n\nABSTRACT.CONCLUSIONS.\nCarbonated water has negative effects on etched or sealed enamel, resulting in decreased microhardness and removal of the adhesive material.",
        "target": "\nThe purpose of this study was to see how different types of carbonated water affect teeth. The researchers made different types of carbonated water and tested how they affected teeth. They found that carbonated water can damage teeth, especially if it has a lot of carbon dioxide or calcium in it. They also found that the damage can be seen under a special microscope called a scanning electron microscope.\nSo Poorly written passage. I hope this helps!",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        1196,
                        1370
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.ABSTRACT:\nABSTRACT.BACKGROUND AND AIMS::\nRecent studies have shown that etomidate is associated with fewer serious adverse events than propofol and has a noninferior sedative effect. We investigated whether etomidate\u2013midazolam is associated with fewer cardiopulmonary adverse events and has noninferior efficacy compared to propofol\u2013midazolam for screening colonoscopy in the elderly.\n\nABSTRACT.METHODS::\nA prospective, single-center, double-blinded, randomized controlled trial was performed. Patients aged over 65 years who were scheduled to undergo screening colonoscopy were randomized to receive either etomidate or propofol based on midazolam. The primary outcome was all cardiopulmonary adverse events. The secondary outcomes were vital sign fluctuation (VSF), adverse events disturbing the procedure, and sedation-related outcomes.\n\nABSTRACT.RESULTS::\nThe incidence of cardiopulmonary adverse events was higher in the propofol group (72.6%) than in the etomidate group (54.8%) (P\u200a=\u200a.040). VSF was detected in 17 (27.4%) and 31 (50.0%) patients in the etomidate and propofol groups, respectively (P\u200a=\u200a.010). The incidence rate of adverse events disturbing the procedure was significantly higher in the etomidate group (25.8%) than in the propofol group (8.1%) (P\u200a=\u200a.008). Moreover, the incidence rate of myoclonus was significantly higher in the etomidate group (16.1%) than in the propofol group (1.6%) (P\u200a=\u200a.004). There was no statistical significance between the 2 groups with respect to sedation times and sedation-related outcomes including patients\u2019 and endoscopist's satisfaction. In the multivariate analysis, the etomidate group had significantly low odds ratio (OR) associated with VSF (OR: 0.407, confidence interval: 0.179\u20130.926, P\u200a=\u200a.032).\n\nABSTRACT.CONCLUSIONS::\nWe recommend using etomidate\u2013midazolam in patients with high ASA score or vulnerable to risk factors; propofol\u2013midazolam may be used as a guideline in patients with low ASA score.",
        "target": "This study compared the safety and efficacy of etomidate\u2013midazolam and propofol\u2013midazolam for screening colonoscopy in the elderly. The results showed that etomidate\u2013midazolam was associated with fewer cardiopulmonary adverse events and had noninferior efficacy compared to propofol\u2013midazolam. Furthermore, the etomidate\u2013midazolam group had significantly lower odds ratio for vital sign fluctuation compared to the propofol\u2013midazolam group. Therefore, etomidate\u2013midazolam is recommended for patients with high ASA score or vulnerable to risk factors, while propofol\u2013midazolam can be used as a guideline for patients with low ASA score.&lt;/s&gt;&lt;s&gt;",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        870,
                        1005
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1006,
                        1123
                    ]
                ]
            },
            {
                "category": "results",
                "id": 8,
                "input_idx": [
                    [
                        1298,
                        1431
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.ABSTRACT:\nABSTRACT.BACKGROUND AND AIMS::\nRecent studies have shown that etomidate is associated with fewer serious adverse events than propofol and has a noninferior sedative effect. We investigated whether etomidate\u2013midazolam is associated with fewer cardiopulmonary adverse events and has noninferior efficacy compared to propofol\u2013midazolam for screening colonoscopy in the elderly.\n\nABSTRACT.METHODS::\nA prospective, single-center, double-blinded, randomized controlled trial was performed. Patients aged over 65 years who were scheduled to undergo screening colonoscopy were randomized to receive either etomidate or propofol based on midazolam. The primary outcome was all cardiopulmonary adverse events. The secondary outcomes were vital sign fluctuation (VSF), adverse events disturbing the procedure, and sedation-related outcomes.\n\nABSTRACT.RESULTS::\nThe incidence of cardiopulmonary adverse events was higher in the propofol group (72.6%) than in the etomidate group (54.8%) (P\u200a=\u200a.040). VSF was detected in 17 (27.4%) and 31 (50.0%) patients in the etomidate and propofol groups, respectively (P\u200a=\u200a.010). The incidence rate of adverse events disturbing the procedure was significantly higher in the etomidate group (25.8%) than in the propofol group (8.1%) (P\u200a=\u200a.008). Moreover, the incidence rate of myoclonus was significantly higher in the etomidate group (16.1%) than in the propofol group (1.6%) (P\u200a=\u200a.004). There was no statistical significance between the 2 groups with respect to sedation times and sedation-related outcomes including patients\u2019 and endoscopist's satisfaction. In the multivariate analysis, the etomidate group had significantly low odds ratio (OR) associated with VSF (OR: 0.407, confidence interval: 0.179\u20130.926, P\u200a=\u200a.032).\n\nABSTRACT.CONCLUSIONS::\nWe recommend using etomidate\u2013midazolam in patients with high ASA score or vulnerable to risk factors; propofol\u2013midazolam may be used as a guideline in patients with low ASA score.",
        "target": "This passage is about a study on two different types of medicine that doctors use to make people sleepy before a colonoscopy, a test that checks the inside of your colon. The doctors wanted to know which medicine, etomidate or propofol, is safer for elderly people and just as good at making them sleepy.\n\nThey found that more people who took propofol had problems with their heart and lungs compared to those who took etomidate. People who took etomidate were more likely to have their test interrupted by these problems. However, both groups were almost equally satisfied with how sleepy they were during the test. \n\nSo, the doctors suggest that for people who are at high risk of heart and lung problems, etomidate is a better choice. But, for people with lower risk, both propofol and etomidate can be used safely.",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        870,
                        1005
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1006,
                        1123
                    ]
                ]
            },
            {
                "category": "results",
                "id": 8,
                "input_idx": [
                    [
                        1298,
                        1431
                    ]
                ]
            }
        ]
    },
    {
        "source": "ABSTRACT.ABSTRACT:\nABSTRACT.BACKGROUND AND AIMS::\nRecent studies have shown that etomidate is associated with fewer serious adverse events than propofol and has a noninferior sedative effect. We investigated whether etomidate\u2013midazolam is associated with fewer cardiopulmonary adverse events and has noninferior efficacy compared to propofol\u2013midazolam for screening colonoscopy in the elderly.\n\nABSTRACT.METHODS::\nA prospective, single-center, double-blinded, randomized controlled trial was performed. Patients aged over 65 years who were scheduled to undergo screening colonoscopy were randomized to receive either etomidate or propofol based on midazolam. The primary outcome was all cardiopulmonary adverse events. The secondary outcomes were vital sign fluctuation (VSF), adverse events disturbing the procedure, and sedation-related outcomes.\n\nABSTRACT.RESULTS::\nThe incidence of cardiopulmonary adverse events was higher in the propofol group (72.6%) than in the etomidate group (54.8%) (P\u200a=\u200a.040). VSF was detected in 17 (27.4%) and 31 (50.0%) patients in the etomidate and propofol groups, respectively (P\u200a=\u200a.010). The incidence rate of adverse events disturbing the procedure was significantly higher in the etomidate group (25.8%) than in the propofol group (8.1%) (P\u200a=\u200a.008). Moreover, the incidence rate of myoclonus was significantly higher in the etomidate group (16.1%) than in the propofol group (1.6%) (P\u200a=\u200a.004). There was no statistical significance between the 2 groups with respect to sedation times and sedation-related outcomes including patients\u2019 and endoscopist's satisfaction. In the multivariate analysis, the etomidate group had significantly low odds ratio (OR) associated with VSF (OR: 0.407, confidence interval: 0.179\u20130.926, P\u200a=\u200a.032).\n\nABSTRACT.CONCLUSIONS::\nWe recommend using etomidate\u2013midazolam in patients with high ASA score or vulnerable to risk factors; propofol\u2013midazolam may be used as a guideline in patients with low ASA score.",
        "target": "\n\nSo, doctors did a special test to see which medicine is better for people who are going to have a colonoscopy. They found out that one medicine, called etomidate, is safer and works better than another medicine, called propofol, for some people. They looked at how often people had problems with their heart or breathing during the test, and they found that the etomidate group had fewer problems. They also looked at how long it took for the medicine to start working, and they found that it worked just as well as the other medicine. They think that doctors should use the etomidate medicine more often for people who are at higher risk of having problems during the test.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\u0434\u0436\u0430\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n KinderGART\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS MS\n\n\n\n\nMS\nMS MS-\nMS MSMS-MMS-MS\n\n\n\n\n\n\n\n\n\n\nMS-\nMS-M\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS\nMS-MS\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS\n\nMS-MS\n\nMS-MS\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\nMS-MS\nMS-MS\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS-MS\n\n\n\n\n\n\n\n\nMS-MS-MS-MS\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\nMS-MS\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\nMS-MS-MS\nMS-MS\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS-MS\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\nMS-MS-MS-MS\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\nMS-MS-MS- styles\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS-MS\n\n\n\n\n\n\n\nMS-MS-MS-MS\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS-MS\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\nMS-MS-MS\nMS\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\nMS-MS-MS\nMS\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\nMS-MS-MS\nMS\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\nMS-MS-MS\nMS\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\nMS-MS-MS\nMS\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\nMS-MS-MS\nMS\n\n\n\n\n\n\n\nMS-MS-MS\nMS\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\nMS-MS-MS\nMS\n\n\n\n\n\nMS-MS-MS\nMS\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\nMS-MS-MS\nMS\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\nMS\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\nMS-MS-MS-MS\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS-MS\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS-MS\n\n\n\n\n\n\n\n\n\n\nMS-MS-MS\n\n\n\n\n\n\n\n\n\n\n\nMS-",
        "edits": [
            {
                "category": "hol_eval",
                "id": 0
            },
            {
                "category": "final_q",
                "id": 1
            },
            {
                "category": "pico_pop",
                "id": 2
            },
            {
                "category": "pico_inter",
                "id": 3
            },
            {
                "category": "pico_comp",
                "id": 4
            },
            {
                "category": "pico_out",
                "id": 5
            },
            {
                "category": "results",
                "id": 6,
                "input_idx": [
                    [
                        870,
                        1005
                    ]
                ]
            },
            {
                "category": "results",
                "id": 7,
                "input_idx": [
                    [
                        1006,
                        1123
                    ]
                ]
            },
            {
                "category": "results",
                "id": 8,
                "input_idx": [
                    [
                        1298,
                        1431
                    ]
                ]
            }
        ]
    }
]